Trial Profile
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 09 Apr 2014 New trial record